Future unrelated medical costs need to be considered in cost effectiveness analysis

Pieter van Baal, Alec Morton, David Meltzer, Werner Brouwer

Research output: Contribution to journalArticle

7 Citations (Scopus)
10 Downloads (Pure)


New medical technologies that prolong life result in additional health care use in life years gained. Some of these costs in life years gained are considered to be related to the intervention while other costs are considered unrelated. Here, we argue that ignoring these so-called future medical costs in cost effectiveness analysis is contrary to common sense, results in lost health and fails to inform decision makers for whom cost effectiveness is supposed to serve.

Original languageEnglish
Pages (from-to)1-5
JournalEuropean Journal of Health Economics
Issue number1
Early online date18 Apr 2018
Publication statusPublished - 7 Feb 2019


  • health care expenditure
  • cost effective
  • future medical costs

Cite this